Development, manufacturing and the sale of cephalosporin and system specific (generic) medicines are the core businesses of our group. The R & D Centre of Dawnrays Pharmaceutical has developed a series of strong technological capabilities, including a comprehensive vertically integrated production process of the third and the fourth generations of cephalosporins, R & D expertise, comprehensive technologies and equipment in research and development of system specific medicine synthesis and new types of preparations, and extensive experience in declaration and regulation compliance. Dawnrays Pharmaceutical is equipped with advanced production facilities, strong production management and production capacity to cover a comprehensive formulation including the 7ACA (cephalosporin raw materials), powder for injection, tablets, capsules, granules, and etc.

Our Group can provide product research, contract-out R & D services, declaration and regulation compliance services, and custom manufacturing processing to local and overseas pharmaceutical companies and sales suppliers. Dawnrays also welcomes strategic partnership and collaboration with international pharmaceutical companies for new species of drugs development, drugs synthesis and new types of preparations technology exchange.

For enquiries, please contact :

Hong Kong Office
Ms.  Yeung             Email: ir@dawnrays.com.hk